The FDA has reported that 2/3 of the drugs approved by the agency remain untested and unproven. When new drugs are approved for public use, they are supposed to report the results of clinical trials to the FDA. One drug approved in 1955 has still not complied with these tests. These studies are important in that they are intended to reveal if the drugs are working as intended and whether they...
In July 2005 it was the fentanyl patch used for chronic pain. The following November it was the Ortho Evra birth control patch after studies had shown women using the patch were exposed to 60% more estrogen than non-users. Now, the FDA is going to probe the entire drug patch industry for safety concerns. There are inherent issues with the patch such as increased exposure to heat. "Most...
Check out fellow Injury Board blogger Kerry Jardine's post on pharmacy mistakes.When you get a prescription filled at your drug store, make sure the pharmacist has filled it correctly. The consequences of taking the wrong prescription can be dire or fatal depending upon the severity of the mistake. Unfortunately, such mistakes are more common than you'd like to think.
The Public Citizen has petitioned the U.S. Food and Drug Administration (FDA) to immediately begin to phase out the widely prescribed pain reliever propoxyphene (Darvon, Darvocet and generic versions) from the market because the drug has been associated with more than 2,000 accidental deaths, is physically addictive and is no more effective than safer alternatives.
Bristol-Myers Squibb is warning against the use of the antibiotic drug Tequin in diabetic patients after reports of several fatalities per the FDA. The company has also said its adding a contraindication warning for diabetics to the drug's label as well as strengthening its warning that Tequin can cause both low and high blood sugar levels in patients. Bristol-Myers spokesman Eric Miller said...
Warnings that this antibiotic could cause serious swings in blood pressure were actually added in 2002, so we have to wonder how closely doctors were monitoring the patients involved in the more recent deaths from Tequin.Bristol-Myers Squibb is warning against the use of the antibiotic drug Tequin in diabetic patients after reports of several fatalities, the U.S. Food and Drug Administration...
A new FDA warning alerts consumers about potential dangers of the Ortho Evra® patch. First approved by the FDA in November 2001, the Ortho Evra® birth control patch is a transdermal patch that is applied to the skin and worn for one week.The patch is replaced every week for 3 weeks, followed by one patch-free week. Currently, Ortho Evra® is the only birth control patch available and its...
After Vioxx was removed from the market in 2004, many former Vioxx users started taking Celebrex as a safer alternative for arthritis pain. A recent study from the Medical Research Institute of New Zealand has shown that Celebrex may not be as safe as once thought when compared with other arthritis treatments. Institute Director Richard Beasley noted: "These findings are critical as the risk is...
New Zealand's Medical Research Institute has found that Celebrex users are nearly twice as likely to suffer a heart attack as those taking other arthritis drugs, commonly known as Cox-2 inhibitors. Last August, Pfizer, the manufacturer of Celebrex, put a "black box" warning on the drug yet Celebrex stayed on the market. The black box warning is the most severe of the labels placed on...
The next Vioxx trial, which will begin on March 6, 2006, will be on an entirely new time frame from any other one before it. Manually operated clocks, like those used in a chess game, will be utilized by both sides in order facilitate the pace of the trial. Lawyer's for the Plaintiffs will have 40 hours to present their case, not including opening and closing statements. Counsel for the...
Showing items 2491 to 2500 of 2583